Table 7 shows the poor timing of the company in using OTC derivatives to hedge its position, with h* jumping from approximately U$1 billion to U$7 billion in the second trimester of 2008. Aracruz exposure grew considerably in the months preceding the crisis, and spiked just before the crisis hit. The result, predictably, was a massive restructuring of the company‟s hedging position, the sell-off of its sell target forward position, and the doubling of its liabilities in foreign-currency. In the beginning of 2009 the company was still exposed to exchange-rate risk due to the trading of sell target forwards for more maturing swaps. The financial burden, however, resulted in the company being acquired by its smaller competitor, Votorantim Papel e Celulose (VCP), by approximately U$3 billion in early 2009. The resulting company changed its name to Fibria and is traded in the New York Exchange.